Faze kliničkog istraživanja (Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Faze kliničkog istraživanja" in Croatian language version.

refsWebsite
Global rank Croatian rank
4th place
13th place
2nd place
12th place
1st place
1st place
low place
low place
1,684th place
2,944th place
719th place
540th place
low place
low place

bio.org

cancer.ca

cancer.gov

doi.org

  • Fisher, JA. 1. ožujka 2015. Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials. Science, Technology & Human Values. 40 (2): 199–226. doi:10.1177/0162243914554838. PMC 4405793. PMID 25914430
  • Arrowsmith, John. 1. veljače 2011. Trial watch: Phase III and submission failures: 2007–2010. Nat Rev Drug Discov. 10 (2): 87. doi:10.1038/nrd3375. PMID 21283095
  • Holland, John. 2013. Fixing a broken drug development process. Journal of Commercial Biotechnology. 19. doi:10.5912/jcb588
  • Adams, C. P.; Brantner, V. V. 2006. Estimating the Cost of New Drug Development: Is It Really $802 Million?. Health Affairs. 25 (2): 420–8. doi:10.1377/hlthaff.25.2.420. PMID 16522582

medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Fisher, JA. 1. ožujka 2015. Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials. Science, Technology & Human Values. 40 (2): 199–226. doi:10.1177/0162243914554838. PMC 4405793. PMID 25914430
  • Adil E. Shamoo. 2008. The Myth of Equipoise in Phase 1 Clinical Trials. Medscape J Med. 10 (11): 254. PMC 2605120. PMID 19099004
  • Arrowsmith, John. 1. veljače 2011. Trial watch: Phase III and submission failures: 2007–2010. Nat Rev Drug Discov. 10 (2): 87. doi:10.1038/nrd3375. PMID 21283095
  • Adams, C. P.; Brantner, V. V. 2006. Estimating the Cost of New Drug Development: Is It Really $802 Million?. Health Affairs. 25 (2): 420–8. doi:10.1377/hlthaff.25.2.420. PMID 16522582

ncbi.nlm.nih.gov

  • Fisher, JA. 1. ožujka 2015. Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials. Science, Technology & Human Values. 40 (2): 199–226. doi:10.1177/0162243914554838. PMC 4405793. PMID 25914430
  • Adil E. Shamoo. 2008. The Myth of Equipoise in Phase 1 Clinical Trials. Medscape J Med. 10 (11): 254. PMC 2605120. PMID 19099004

web.archive.org